Browse
We’re here to help

Find guidance on Author Services

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Orphan Drugs
List of Issues
Volume 4, Issue 5

Expert Opinion on Orphan Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Current issue
All volumes & issues
Special issues
Collections
Most read articles
Most cited articles

New content alerts
RSS

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Orphan Drugs, Volume 4, Issue 5 (2016)

Browse this journal

Current issue
List of issues
Special issues
Collections
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Orphan Drugs, Volume 4, Issue 5 (2016)

See all volumes and issues

Vol 12, 2024 Vol 11, 2023 Vol 10, 2022 Vol 9, 2021 Vol 8, 2020 Vol 7, 2019 Vol 6, 2018 Vol 5, 2017 Volume 4, 2016 Vol 3, 2015 Vol 2, 2014 Vol 1, 2013

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

G-BA benefit assessment of new orphan drugs in Germany: the first five years

Meriem Bouslouk

Pages: 453-455

Published online: 30 Mar 2016

First Page PreviewforG-BA benefit assessment of new orphan drugs in Germany: the first five years | Full Text | References | PDF (272.9 KB)

10270 Views
11 CrossRef citations
0Altmetric

Free Access

Editorial

Challenges and opportunities when developing devices for rare disease populations

Maryam Mokhtarzadeh, Malvina Eydelman & Eric Chen

Pages: 457-459

Published online: 25 Mar 2016

First Page PreviewforChallenges and opportunities when developing devices for rare disease populations | Full Text | References | PDF (310.3 KB)

1421 Views
1 CrossRef citations
0Altmetric

Free Access

Review

Therapeutic options in frontal fibrosing alopecia

Raymond Fertig, Nouf M. Aleid & Tosti Antonella

Pages: 461-468

Published online: 18 Apr 2016

AbstractforTherapeutic options in frontal fibrosing alopecia | Full Text | References | PDF (578.7 KB)

91 Views
1 CrossRef citations
0Altmetric

Therapeutic targets and emerging treatment options in gastrointestinal acute graft-versus-host disease

Anne S. Renteria, John E. Levine & James L. M. Ferrara

Pages: 469-484

Published online: 06 Apr 2016

AbstractforTherapeutic targets and emerging treatment options in gastrointestinal acute graft-versus-host disease | Full Text | References | PDF (1.6 MB)

269 Views
3 CrossRef citations
0Altmetric

Novel treatment perspectives from advances in understanding of genetic epilepsy syndromes

Alberto Verrotti, Federico Zara, Carlo Minetti & Pasquale Striano

Pages: 485-490

Published online: 28 Mar 2016

AbstractforNovel treatment perspectives from advances in understanding of genetic epilepsy syndromes | Full Text | References | PDF (506.9 KB)

70 Views
0 CrossRef citations
0Altmetric

Orphan drug approvals of 2015: Europe and the United States

Peter Norman

Pages: 491-500

Published online: 11 Apr 2016

AbstractforOrphan drug approvals of 2015: Europe and the United States | Full Text | References | PDF (711.8 KB)

210 Views
2 CrossRef citations
0Altmetric

Is there a role for pomalidomide in the treatment of myelofibrosis?

Samah Alimam & Claire Harrison

Pages: 501-509

Published online: 06 Apr 2016

AbstractforIs there a role for pomalidomide in the treatment of myelofibrosis? | Full Text | References | PDF (803 KB)

35 Views
0 CrossRef citations
0Altmetric

New targets in idiopathic pulmonary fibrosis: from inflammation and immunity to remodeling and repair

Antoine Froidure, Audrey Joannes, Arnaud A. Mailleux & Bruno Crestani

Pages: 511-520

Published online: 12 Apr 2016

AbstractforNew targets in idiopathic pulmonary fibrosis: from inflammation and immunity to remodeling and repair | Full Text | References | PDF (1 MB)

192 Views
4 CrossRef citations
0Altmetric

New drugs for myelofibrosis

Gabriela Hobbs & Ruben Mesa

Pages: 521-529

Published online: 08 Apr 2016

AbstractforNew drugs for myelofibrosis | Full Text | References | PDF (648.6 KB)

120 Views
2 CrossRef citations
0Altmetric

Drug Evaluation

Article

Pasireotide for treating acromegaly

Marcello D. Bronstein & Raquel S. Jallad

Pages: 531-540

Published online: 12 Apr 2016

AbstractforPasireotide for treating acromegaly | Full Text | References | PDF (1,013.3 KB)

56 Views
0 CrossRef citations
0Altmetric

Article

Nanoliposomal irinotecan for treating pancreatic cancer

Dimitra Grapsa, Konstantinos Syrigos & Muhammad Wasif Saif

Pages: 541-547

Published online: 13 Apr 2016

AbstractforNanoliposomal irinotecan for treating pancreatic cancer | Full Text | References | PDF (570.6 KB)

99 Views
3 CrossRef citations
0Altmetric

Article

Vonicog alfa for the treatment of von Willebrand disease

Giancarlo Castaman & Silvia Linari

Pages: 549-554

Published online: 15 Apr 2016

AbstractforVonicog alfa for the treatment of von Willebrand disease | Full Text | References | PDF (497.8 KB)

109 Views
2 CrossRef citations
0Altmetric

Article

Fosbretabulin tromethamine in the treatment of thyroid cancer

Jolanta Krajewska & Barbara Jarzab

Pages: 555-561

Published online: 04 Apr 2016

AbstractforFosbretabulin tromethamine in the treatment of thyroid cancer | Full Text | References | PDF (563.7 KB)

30 Views
3 CrossRef citations
0Altmetric

Retraction

Page: 562

Published online: 30 Mar 2016

CitationforRetraction | Full Text | PDF (86.8 KB)

429 Views
0 CrossRef citations
0Altmetric

Free Access

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Current and emerging therapies for the treatment of leishmaniasis

Shyam Sundar et al.

Review Article | Published online: 1 Apr 2024

Open Access

The Orphan Drug Act and rare cancers: a retrospective analysis of oncologic orphan drug designations and associated approvals from 1983-2022

Abraham Viju Ipe et al.

Article | Published online: 26 Mar 2024

Open Access

Orphan drugs approved in Canada: health technology assessment, price negotiation, and government formulary listing

Nigel S B. Rawson et al.

Article | Published online: 13 Feb 2024

Open Access

Overview of genetic testing in Prader-Willi syndrome

Ying Gao et al.

Review Article | Published online: 28 Sep 2023

Open Access

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Orphan Drugs (Vol.4, Iss.5, 2016)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?